Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00880230 · ClinicalTrials.gov registry record · NA
Iliac Artery Treatment With The Invatec Scuba™ Cobalt Chromium Stent (INTENSE)
A NA study, sponsored by Medtronic Endovascular.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
NCT00880230 is a NA study that has completed, run by Medtronic Endovascular. The registered enrollment target is 141 participants.
The verdict
NCT00880230, a NA study, has completed, sponsored by Medtronic Endovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of the Scuba™ stent in subjects with symptomatic claudication or rest pain and angiographic confirmation of de novo or restenotic lesions in the common and/or external iliac artery.
Interventions
- DEVICE Scuba Iliac Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2009-03 |
| Est. Completion | 2012-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00880230
The ClinicalTrials.gov registry entry for NCT00880230 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Endovascular, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Scuba Iliac Stent System is the first listed.
NCT00880230 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00880230 about?
NCT00880230 is a clinical study titled "Iliac Artery Treatment With The Invatec Scuba™ Cobalt Chromium Stent (INTENSE)". The purpose of this study is to determine the safety and effectiveness of the Scuba™ stent in subjects with symptomatic claudication or rest pain and angiographic confirmation of de novo or restenotic lesions in the common and/or external iliac artery.
What is the current status of trial NCT00880230?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2009-03. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00880230?
The interventions under investigation include: Scuba Iliac Stent System (DEVICE).
Who is sponsoring clinical trial NCT00880230?
This trial is sponsored by Medtronic Endovascular, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.